Hematology and clinical chemistry values in pregnant Wistar Hannover rats compared with nonmated controls

Veterinary Clinical Pathology

Volumn 33, Issue 2, 2004, Pages 68-73

  Liberati, Teresa A ^a,b   Sansone, Sandra R ^a   Feuston, Maureen H ^a  

^a Sanofi Synthelabo   (United States)

^b Taconic Anmed   (United States)

Author keywords

Clinical chemistry; Gestation; Hematology; Pregnancy; Safety assessment; Wistar hannover rat

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; CALCIUM; CHLORIDE; CHOLESTEROL; CREATINE KINASE; GLOBULIN; GLUCOSE; PHOSPHORUS; TRIACYLGLYCEROL; UREA; WATER;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CELL COUNT; CLINICAL CHEMISTRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; EVALUATION; FEMALE; GESTATION PERIOD; HEMATOLOGY; LABORATORY TEST; LEUKOCYTE; LYMPHOCYTE; MATING; MEAN CORPUSCULAR HEMOGLOBIN; MONOCYTE; NEUTROPHIL; NONHUMAN; PREGNANCY; RAT; RAT STRAIN; RETICULOCYTE; THROMBOCYTE;

ANIMALIA;

EID: 4143067015     PISSN: 02756382     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-165X.2004.tb00352.x     Document Type: Article

References (28)

1. Mid-Atlantic Reproduction and Teratology Association (MARTA) and the Midwest Teratology Association (MTA). Historical control data (1992-1994) for developmental and reproductive toxicity studies using the Crl:CD®(SD) BR rat. Wilmington, MA: Charles River Laboratories; 1996.
2. Hooks WN, Harling RJ. A review of the choice of rat strain in tumorigenicity studies [abstract]. Toxicol Lett. 2000;229:62.
3. Liberati TA, Roe BJ, Feuston MF. An oral (gavage) control embryo-fetal developmental study in the Wistar Hanover rat. Drug and Chem Toxicol. 2002;25:109-130.
4. Good laboratory practice for nonclinical laboratory studies. Code of Federal Regulations, Title 21 (1), Part 58; Food and Drug Administration. Washington, DC: Dept of Health and Human Services; 2001:302-316.
5. International Conference on Harmonization (ICH). Guideline on Detection of Toxicity to Reproduction for Medicinal Products, Federal Register 59, No. 183, Section 4.1.3; September 22, 1994.
6. IFCC. Approved recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem. 1987;25:645-656.
7. Yang JJ, Krueger AJ, Roy TA, Feuston MH. Serum chemistry assays in reproduction toxicity testing [abstract]. Clin Chem. 1988;34:181.
8. LaBorde JB, Wall KS, Bolon B, et al. Haematology and serum chemistry parameters of the pregnant rat. Lab Anim. 1999;33:275-287.
9. Papworth TA, Clubb SK. Clinical pathology in the female rat during the pre- and postnatal period. Comp Hematol Int. 1995;5:13-24.
10. De Rijk EPCT, Eseh EV, Flik G. Pregnancy dating in the rat: placental morphology and maternal blood parameters. Toxicol Path. 2002;30:271-282.
11. Kim JC, Yun HI, Lim KH, Suh JE, Chung MK. Haematological values during normal pregnancy in Sprague-Dawley rats. Comp Hematol Int. 2000;10:74-79.
12. Wells MY, Decobecq CPM, Decouvelaere DM, Justice C, Guittin P. Changes in clinical pathology parameters during gestation in the New Zealand White rabbit. Toxicol Pathol. 1999;27:370-379.
13. Lind T. Clinical chemistry of pregnancy. In: Latner A., Schwartz M., eds. Advances in Clinical Chemistry. Vol. 21. London: Academic Press Inc; 1980:1-24.
14. Calvert SM, Tuffnell DJ, Haley J. Poor predictive value of platelet count, mean platelet volume and serum urate in hypertension in pregnancy. Eur J Obstet Gynecol Reprod Biol. 1996;64:179-184.
15. Baylis C. Glomerular filtration rate and plasma volume in the pregnant rat. J Physiol. 1980;305:49-50.
16. Lurie S, Danon D. Life span of erythrocytes in late pregnancy. Obstet Gynecol. 1992;80:123-126.
17. Brizzi P, Tonolo G, Esposito F. Lipoprotein metabolism during normal pregnancy. Am J Obstet Gynecol. 1999;181:430-434.
18. Chiang AN, Yang ML, Hung JH, Chou P, Shyn SK, Ng HT. Alterations of serum lipid levels and their biological relevances during and after pregnancy. Life Sci. 1995;56:2367-2375.
19. Alberty R. Biological variability of twenty-five serum analytes during normal pregnancy. Clin Chim Acta. 1993;214:245-248.
20. Ramirez I, Llobera M, Herrera E. Circulating triacylglycerols, lipoproteins, and tissue lipoprotein lipase activities in rat mothers and offspring during the perinatal period: effect of postmaturity. Metabolism. 1983;32:333-341.
21. Herrera E, Lasuncion MA, Gomez-Coronado D, Aranda P, Lopez-Luna P, Maier I. Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy. Am J Obstet Gynecol. 1988;158:1575-1583.
22. Shambang GE, Morosak SC, Freinkel N. Fetal fuels. I. Utilisation of ketones by isolated tissues at various stages of maturation and maternal nutrition during late gestation. Metabolism. 1977;26:623-635.
23. Wasfi I, Weinstein I, Heimberg M. Increased formation of triglyceride from oleate in perfused livers from pregnant rats. Endocrinology. 1980;107:584-590.
24. Soria A, Chicco A, Mocchiutti N, et al. A sucrose-rich diet affects triglyceride metabolism differently in pregnant and non-pregnant rats and has negative effects on fetal growth. J Nutr. 1996;126:2481-2486.
25. Bacq Y, Zarka O, Brechot JF, et al. Liver function tests in normal pregnancy: a prospective study of 103 patients and 103 matched controls. Hepatology. 1996;23:1030-1034.
26. Palm M. Clinical pathology values in pregnant and non-pregnant rabbits. Scand J Lab Anim Sci. 1997;24:177-183.
27. Munilla MA, Herrera E. A cholesterol-rich diet causes a greater hypercholesterolemic response in pregnant than in nonpregnant rats and does not modify fetal lipoprotein profile. J Nutr. 1997;127:2239-2245.
28. Mendenhall H. Serum protein concentrations in pregnancy. Am J Obstet Gynecol. 1970;106:388-399.